tiprankstipranks
Advertisement
Advertisement

Beam Therapeutics treatment of sickle cell disease granted orphan designation

The FDA granted orphan designation to a treatment of sickle cell disease being developed by Beam Therapeutics (BEAM), according to a post to the agency’s website.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1